Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Micrografts improve hair density and thickness without side effects.

Low-dose UVB light improves hair growth effects of certain stem cells by increasing reactive oxygen species.

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Fungal infections in lab animals can interfere with research.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Adipose-derived stem cells show promise in treating skin conditions like vitiligo, alopecia, and nonhealing wounds.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.